Compare Northrop Grumman Corporation (NOC) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Northrop Grumman Corporation vs Regeneron Pharmaceuticals Inc — how do they compare? Northrop Grumman Corporation trades at $512.35 (market cap $74.42B), while Regeneron Pharmaceuticals Inc trades at $670 (market cap $70.47B). The key difference: Northrop Grumman Corporation and Regeneron Pharmaceuticals Inc are close in size by market cap, and Northrop Grumman Corporation pays the higher dividend (1.79%). Which is the better fit depends on your goals.
| NOC | REGN | |
|---|---|---|
Market Cap | $74.42B | $70.47B |
Sector | Industrials | Health |
52-Week High | $768.02 | $812.27 |
52-Week Low | $496.02 | $545.46 |
Enterprise Value | $88.65B | $64.42B |
Dividend Yield | 1.79% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Northrop Grumman Corporation
Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
